Orchard Therapeutics
Budget
€10 — €0
EP Access
0
accredited persons
Staff
1
0.1 FTE
EU Grants
None
Mission & Goals
Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy.
EU Legislative Interests
EU pharma strategy OMP legislation ATMP legislation Health Technology Assessment Cross border directive Social Security legislation
Communication Activities
Cross border healthcare - all rare disease related policies - European Reference Networks, - EU research agenda - new born screening - real world evidence
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
ARM - Alliance for Regenerative Medicine EUCOPE
Organisation Members
N/A
Commissioner Meetings
No recorded meetings with EU commissioners.